Top Markets
#1 Seeker Seeker +146.01%
#2 MowCat MowCat +109.02%
#3 AI XOVIA AI XOVIA +103.40%
#4 Helium Helium +97.25%
#5 Pons Pons +43.39%
#6 UnifAI Network UnifAI Network +33.44%
#7 Zora Zora +30.95%
#8 Bounce Bounce +22.78%
#9 Zylo Ecosystem Zylo Ecosystem +22.03%
#10 pipedog pipedog +15.70%
Coin of the day
Seeker Seeker
Settings
Language
ENGLISH
Currency
USD
Theme
Zhejiang Wecome Pharmaceutical Company Limited Zhejiang Wecome Pharmaceutical Company Limited

Zhejiang Wecome Pharmaceutical Company Limited

300878
Rank in Stocks #11789
Zhejiang Wecome Pharmaceutical Company Limited primarily focuses on the... Zhejiang Wecome Pharmaceutical Company Limited primarily focuses on the innovation, manufacturing, and distribution of pharmaceutical products. Beyond its core medicinal offerings, the company also provides a range of healthcare items, over-the-counter (OTC) medications, and traditional Chinese remedies. These products are available in numerous formats, including hard and soft capsules, tablets, granules, and pills, among other dosage forms. Established in 2000, the firm, previously known as Zhejiang Weikang Pharmaceutical Co., Ltd., is headquartered in Lishui, China.
Share Price
$4.64
Last synced: 2026-08-28
Market Cap
$658.73M
Change (1 day)
-6.27%
Change (1 year)
60.21%
Country
CN
Trade Zhejiang Wecome Pharmaceutical Company Limited (300878)

Category

Healthcare
Revenue for Zhejiang Wecome Pharmaceutical Company Limited (300878)
Revenue in Aug 2026 TTM: 0
According to Zhejiang Wecome Pharmaceutical Company Limited latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Zhejiang Wecome Pharmaceutical Company Limited from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH